What Is Sapropterin Used For?
Sapropterin (Kuvan) treats phenylketonuria (PKU), a genetic disorder where the body can't break down phenylalanine (Phe), an amino acid in protein-rich foods. High Phe levels damage the brain, leading to intellectual disability and other issues if untreated.[1]
Key Symptoms Prompting Sapropterin Consideration
Sapropterin is considered for PKU patients with hyperphenylalaninemia—specifically blood Phe levels above 10 mg/dL (600 μmol/L) despite dietary management. Symptoms driving evaluation include:
- Developmental delays or cognitive impairment from chronic high Phe.
- Behavioral problems like hyperactivity, anxiety, or autism-like traits.
- Neurological signs such as seizures, tremors, or poor coordination.
- In newborns, elevated Phe detected via screening, preventing symptoms like musty breath odor, eczema, or fair skin/hair.[1][2]
It's tested via a 4-week challenge: patients take 20 mg/kg/day; responders (Phe drop ≥30%) continue therapy alongside diet.[1]
How Doctors Decide to Try It
Physicians consider sapropterin after confirming PKU diagnosis and poor dietary control. It's for ages 1 month+ (FDA-approved for 4+), especially if Phe stays high despite low-Phe diet. Non-responders (~60% of cases) stick to diet alone.[1][3]
What If Symptoms Persist Without Treatment?
Untreated high Phe causes irreversible brain damage by disrupting neurotransmitter production and myelin formation. Symptoms worsen over time: IQ drops 1-4 points per 1 mg/dL Phe rise above normal. Sapropterin helps ~40% by boosting phenylalanine hydroxylase enzyme activity.[2][4]
Testing Response and Monitoring
Start with baseline Phe levels, then measure weekly during trial. Success requires ≥30% reduction and Phe <360 μmol/L. Long-term, monitor growth, neurodevelopment, and side effects like headache or rash.[1]
[1]: FDA Label for Kuvan (sapropterin)
[2]: NORD: Phenylketonuria
[3]: BioMarin Patient Resources
[4]: PubMed: Sapropterin in PKU